More about Procter & Gamble Hygiene and Health Care Limited
Fundamentals for Procter & Gamble Hygiene and Health Care Limited
Regulatory Filings for Procter & Gamble Hygiene and Health Care Limited
From Cost Center to Strategic Core: The Top 10 Trends Transforming Finance in 2026
CFOs Seize the Tech Purse Strings: How 2026 Budgets Are Fueling the AI Transformation
From Agentic AI to Tokenized Assets: The Fintech Trends Reshaping Financial Services
Forex Focus: How a Weakening Indian Rupee Could Reshape Markets in Q1 2026
Fundamentals for Procter & Gamble Hygiene and Health Care Limited
Business Operations:
Sector: Consumer DefensiveIndustry: Household & Personal Products
Procter & Gamble Hygiene and Health Care Limited engages in the manufacture and sale of branded packaged fast-moving consumer goods in the feminine care and healthcare businesses in India and internationally. It operates through Healthcare Products and Hygiene Products segments. The company provides health care products, including ointments and creams, cough drops, and tablets; and hygiene products, such as feminine hygiene and other skin care hygiene products, as well as feminine care pads. It also offers baby care products comprising nappies, pants, and baby wipes; grooming products; laundry products; hair care products; home care products; and oral care products. The company offers its products under the Vicks, Whisper, Pampers, Ariel, Tide, Gillette, Head & Shoulders, Herbal Essences, Pantene, Ambi Pur, Oral-B, Olay, and Old Spice brand names. It sells its products through mass merchandisers, as well as grocery, membership club, drug, department, and high frequency stores. The company was incorporated in 1964 and is based in Mumbai, India. Procter & Gamble Hygiene and Health Care Limited operates as a subsidiary of The Procter & Gamble Company.
Revenue projections:
PGHH's revenues are expected to fall below last year's, and this forecast tends to raise concerns among investors. A revenue drop can negatively impact the company's profitability, making investors more cautious about their positions due to the risks of declining financial performance.
Financial Ratios:
| currentRatio | 1.370000 |
|---|---|
| forwardPE | 40.747444 |
| debtToEquity | 0.221000 |
| earningsGrowth | -0.010000 |
| revenueGrowth | 0.013000 |
| grossMargins | 0.624290 |
| operatingMargins | 0.239510 |
| trailingEps | 221.260000 |
| forwardEps | 27341.459000 |
PGHH's current ratio of 1.37 highlights the company's ability to easily cover its short-term debt using its available cash and assets. This indicates a strong liquidity position, ensuring PGHH is unlikely to face difficulties in meeting immediate financial obligations.
PGHH's low growth in earnings and revenue points to a likely reduction in profits. This signals a weakening financial performance, indicating the company might face difficulties in staying profitable.
PGHH's positive gross and operating margins reflect its profitability and efficiency. These metrics demonstrate the company's ability to manage costs effectively while generating strong revenue, highlighting its solid financial health and operational effectiveness.
PGHH's forward EPS exceeding its trailing EPS means that the company is expected to increase profitability in the current financial year. This reflects improved earnings potential, signaling that PGHH is likely to outperform its previous year's financial performance.
Price projections:
Over time, Procter & Gamble Hygiene and Health Care Limited's price projections have been gradually lowered, signaling declining confidence in the company's future outlook. The downward revisions suggest analysts are becoming more cautious about Procter & Gamble Hygiene and Health Care Limited's potential for growth.
Recommendation changes over time:
PGHH has been receiving a buy bias from analysts, signaling strong confidence in the stock's future performance. This positive outlook might drive investors to view PGHH as an attractive option for their portfolios, positioning the company as a stable and profitable investment choice.
DISCLAIMER: We provide information and our musings based on events, but nothing on this site can be considered professional advice of any kind.
If you have enjoyed reading, spread the word:
Good prospects:
Companies with the best and the worst fundamentals.
Latest Regulatory Filings for NSE500
Companies with the best and the worst technicals.
Understanding Divergent House Price Movements Worldwide
The 2026 Tariff Tipping Point: When Trade Policy Reaches the Consumer
From Caracas to Commodities: The Market Impact of U.S.–China Friction